Raia Drogasil S.A.
RADLY
$4.54
-$0.04-0.87%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.94B | 7.42B | 7.16B | 7.10B | 7.23B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.94B | 7.42B | 7.16B | 7.10B | 7.23B |
| Cost of Revenue | 5.61B | 5.25B | 5.05B | 5.00B | 5.08B |
| Gross Profit | 2.33B | 2.18B | 2.11B | 2.10B | 2.15B |
| SG&A Expenses | 1.85B | 1.75B | 1.69B | 1.69B | 1.71B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -6.35M | -6.35M | -6.35M | -5.07M | 1.57M |
| Total Operating Expenses | 7.45B | 6.98B | 6.74B | 6.69B | 6.79B |
| Operating Income | 487.52M | 439.46M | 420.00M | 419.17M | 437.91M |
| Income Before Tax | 260.95M | 253.08M | 232.59M | 241.82M | 264.15M |
| Income Tax Expenses | 26.59M | 12.60M | 15.73M | 29.47M | 40.96M |
| Earnings from Continuing Operations | 234.36 | 240.48 | 216.86 | 212.35 | 223.19 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -521.10K | -3.16M | -2.49M | -1.30M | -2.22M |
| Net Income | 233.84M | 237.32M | 214.37M | 211.05M | 220.97M |
| EBIT | 487.52M | 439.46M | 420.00M | 419.17M | 437.91M |
| EBITDA | 639.72M | 573.16M | 551.60M | 548.17M | 569.27M |
| EPS Basic | 0.14 | 0.14 | 0.13 | 0.11 | 0.12 |
| Normalized Basic EPS | 0.10 | 0.09 | 0.09 | 0.08 | 0.08 |
| EPS Diluted | 0.14 | 0.14 | 0.13 | 0.11 | 0.12 |
| Normalized Diluted EPS | 0.10 | 0.09 | 0.09 | 0.08 | 0.08 |
| Average Basic Shares Outstanding | 6.59B | 6.72B | 6.72B | 7.97B | 7.97B |
| Average Diluted Shares Outstanding | 6.62B | 6.75B | 6.75B | 7.99B | 8.00B |
| Dividend Per Share | 0.05 | 0.04 | 0.05 | 0.03 | 0.02 |
| Payout Ratio | 50.54% | 39.94% | 44.30% | 40.81% | 38.98% |